Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Receivables (2016 - 2025)

Healthy Extracts filings provide 11 years of Receivables readings, the most recent being $187750.0 for Q4 2025.

  • On a quarterly basis, Receivables rose 1606.35% to $187750.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $187750.0, a 1606.35% increase, with the full-year FY2025 number at $187750.0, up 1606.35% from a year prior.
  • Receivables hit $187750.0 in Q4 2025 for Healthy Extracts, up from $31264.0 in the prior quarter.
  • In the past five years, Receivables ranged from a high of $187750.0 in Q4 2025 to a low of $3980.0 in Q2 2025.
  • Median Receivables over the past 5 years was $87072.5 (2021), compared with a mean of $76306.1.
  • The widest YoY moves for Receivables: up 1606.35% in 2025, down 95.61% in 2025.
  • Healthy Extracts' Receivables stood at $133340.0 in 2021, then fell by 20.66% to $105794.0 in 2022, then crashed by 71.23% to $30440.0 in 2023, then tumbled by 63.85% to $11003.0 in 2024, then surged by 1606.35% to $187750.0 in 2025.
  • The last three reported values for Receivables were $187750.0 (Q4 2025), $31264.0 (Q3 2025), and $3980.0 (Q2 2025) per Business Quant data.